 |
|
Not enough is known about treating malaria in pregnancy, researchers say
July 20, 2005Few studies compare the effects of different drug regimes in pregnant women, and many of the best studies were conducted in Southeast Asia, where malaria transmission rates are low, says researcher Lois Orton of the University of York in England.
"Reliable research about the benefits and harms of treatments for malaria in pregnant women is scarce," Orton says.
The review appears in the July issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.
In one of the studies analyzed by Orton and colleagues, a combination of the drugs artesunate and mefloquine was slightly better than the drug quinine at clearing malaria parasites from the bloodstream and reducing fever in pregnant women.
The risk of treatment failure was 9 percent less in the group receiving the combination drug regime, compared to treatment failure rates in the quinine group, the researchers found. The study included 106 women in Thailand.
The researchers reviewed six studies of antimalarial drugs in pregnant women in Southeast Asia and Africa. All of the women had uncomplicated malaria, meaning that they were ill and infected with the malaria parasite but not at immediate risk of dying from the disease. The studies included 513 women in their second or third trimester of pregnancy.
The studies tested a variety of antimalarial drugs, which complicated the reviewers' task of determining if any of the drug regimes should be recommended, according to Orton.
"As trials were all rather small and varied in the treatments evaluated, it is not surprising that this review was unable to demonstrate any clear direction for policy," Orton says.
One of the surprising findings of the study, according to the reviewers, was the lack of drug trials conducted in Africa, where malaria is endemic.
According to Dr. Judith Robb-McCord of Roll Back Malaria, a World Health Organization group dedicated to reducing worldwide malaria infection rates by 2010, 30 million women become pregnant each year in sub-Saharan Africa. However, malaria transmission rates in the area are so high that women may have some immunity to the disease by the time they become pregnant, preventing serious illness in some cases.
In Africa, therefore, drug trials focus on prevention rather than treatment of the disease, Orton and colleagues say.
In Asia, on the other hand, transmission rates are low and the disease is unstable, which puts pregnant women at risk for severe, life-threatening cases of malaria.
"Multiple-drug-resistant malaria is widespread in this region, so treatment options are limited and there is a push to find new drugs," Orton explains.
Research shows that pregnant women attract twice the number of mosquitoes as non-pregnant women, which probably increases their risk of contracting malaria. The disease can cause severe anemia and parasitic infection in the fetus and increase the risks of preterm birth and maternal death.
"Clearly, more trials are needed evaluating the current best regimens for malaria," Orton says.
Center for the Advancement of Health
In one of the studies analyzed by Orton and colleagues, a combination of the drugs artesunate and mefloquine was slightly better than the drug quinine at clearing malaria parasites from the bloodstream and reducing fever in pregnant women.
The risk of treatment failure was 9 percent less in the group receiving the combination drug regime, compared to treatment failure rates in the quinine group, the researchers found. The study included 106 women in Thailand.
The researchers reviewed six studies of antimalarial drugs in pregnant women in Southeast Asia and Africa. All of the women had uncomplicated malaria, meaning that they were ill and infected with the malaria parasite but not at immediate risk of dying from the disease. The studies included 513 women in their second or third trimester of pregnancy.
The studies tested a variety of antimalarial drugs, which complicated the reviewers' task of determining if any of the drug regimes should be recommended, according to Orton.
"As trials were all rather small and varied in the treatments evaluated, it is not surprising that this review was unable to demonstrate any clear direction for policy," Orton says.
One of the surprising findings of the study, according to the reviewers, was the lack of drug trials conducted in Africa, where malaria is endemic.
According to Dr. Judith Robb-McCord of Roll Back Malaria, a World Health Organization group dedicated to reducing worldwide malaria infection rates by 2010, 30 million women become pregnant each year in sub-Saharan Africa. However, malaria transmission rates in the area are so high that women may have some immunity to the disease by the time they become pregnant, preventing serious illness in some cases.
In Africa, therefore, drug trials focus on prevention rather than treatment of the disease, Orton and colleagues say.
In Asia, on the other hand, transmission rates are low and the disease is unstable, which puts pregnant women at risk for severe, life-threatening cases of malaria.
"Multiple-drug-resistant malaria is widespread in this region, so treatment options are limited and there is a push to find new drugs," Orton explains.
Research shows that pregnant women attract twice the number of mosquitoes as non-pregnant women, which probably increases their risk of contracting malaria. The disease can cause severe anemia and parasitic infection in the fetus and increase the risks of preterm birth and maternal death.
"Clearly, more trials are needed evaluating the current best regimens for malaria," Orton says.
Center for the Advancement of Health
Malaria Current Events and Malaria News RSSU.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat
Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide.
1930s drug slows tumor growth
Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease.
DNA barcodes: Creative new uses span health, fraud, smuggling, history, more
The scientific ability to quickly and accurately identify species through DNA "barcoding" is being embraced and applied by a growing legion of global authorities - from medical and agricultural researchers to police and customs authorities to palaeontologists and others.
PATH Malaria Vaccine Initiative shares strategy for developing 'next-generation' malaria vaccines
Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria. Malaria is one of the world's deadliest infectious diseases, killing nearly 900,000 people a year, most of them children in sub-Saharan Africa.
Global challenges and opportunities in fighting HIV/AIDS and neglected diseases
Responding to the HIV/AIDS pandemic and tackling so-called neglected tropical diseases are the focus of the November/December 2009 edition of Health Affairs.
Media availability: The role of biomedical research in malaria eradication
Although malaria has been controlled in many local and regional populations, the permanent elimination of malaria parasites throughout the world remains an elusive goal, and the disease continues to claim nearly one million lives each year.
Ineffective monotherapies common in high-burden malarious countries
ACTwatch, a research project led by PSI, in collaboration with the London School of Hygiene and Tropical Medicine, released evidence today that indicates that artemisinin combination therapy, the most effective medicines for treating malaria, continue to have a significantly low presence on the market among populations considered to be most at risk.
New tool promises more accurate antimalarial drug dosing
Scientists at LSTM have developed a tool to support the development of appropriate age-based dosing regimens for malaria drugs.
Cell phones become handheld tools for global development
Mobile phones are on the verge of becoming powerful tools to collect data on many issues, ranging from global health to the environment.
Exon-skipping drug prevents muscle wasting, maintains muscle function in dystrophin deficient mice
An exon skipping PPMO has demonstrated dramatic effects in the prevention and treatment of severely affected, dystrophin and utrophin-deficient mice, preventing severe deterioration of the treated animals and extending their lifespan.
More Malaria Current Events and Malaria News Articles
 |
The Making of a Tropical Disease: A Short History of Malaria (Johns Hopkins Biographies of Disease) by Randall M. Packard (Author) Malaria sickens hundreds of millions of people -- and kills one to three million -- each year. Despite massive efforts to eradicate the disease, it remains a major public health problem in poorer tropical regions. But malaria has not always been concentrated in tropical areas. How did other regions control malaria and why does the disease still flourish in some parts of the globe? From Russia to Bengal to Palm Beach, Randall Packard's far-ranging narrative traces the natural and social forces that help malaria spread and make it deadly. He finds that war, land development, crumbling health systems, and globalization -- coupled with climate change and changes in the distribution and flow of water -- create conditions in which malaria's carrier mosquitoes thrive. The combination of... |
 |
The Malaria Capers : More Tales of Parasites and People, Research and Reality by Robert S. Desowitz (Author) "Reads like a murder mystery. . . . [Desowitz] writes with uncommon lucidity and verse, leaving the reader with a vivid understanding of malaria and other tropical diseases, and the ways in which culture, climate and politics have affected their spread and containment."—New York Times Why, Robert S. Desowitz asks, has biotechnical research on malaria produced so little when it had promised so much? An expert in tropical diseases, Desowtiz searches for answers in this provocative book. . |
![GIANTmicrobes: Malaria (Plasmodium Falciparum) [Toy]](http://ecx.images-amazon.com/images/I/219e7hJvowL._SL160_.jpg) |
GIANTmicrobes: Malaria (Plasmodium Falciparum) [Toy] by Giant Microbes GIANTmicrobes are fun and educationala great way to learn about various health topics and the microscopic critters that are found in and around us. Each microbe character is 5-7 in size--over a million times their actual size! Perfect for teachers, parents and budding scientiststhey also make humorous gifts. Each microbe comes with an information tag including scientific name, an image of the actual microbe, and a mini history and science lesson. Not suitable for children under 3 years. Our products are made by top manufacturers who care about toy safety, quality and value. Your order will ship factory fresh directly from our warehouse to your door. We carefully inspect and beautifully package every order before shipment to ensure that you receive high quality products that are... |
 |
Humanity's Burden: A Global History of Malaria (Studies in Environment and History) by James L.A. Webb Jr. (Author) Humanity's Burden provides a panoramic overview of the history of malaria. It traces the long arc of malaria out of tropical Africa into Eurasia, its transfer to the Americas during the early years of the Columbian exchange, and its retraction from the middle latitudes into the tropics since the late nineteenth century. Adopting a broadly comparative approach to historical patterns and processes, it synthesizes research findings from the natural and social sciences and weaves these understandings into a narrative that reaches from the earliest evidence of malaria infections in tropical Africa up to the present. Written in a style that is easily accessible to non-specialists, it considers the significance of genetic mutations, diet, lifestyle, migration, warfare, palliative and curative... |
 |
Compiled 1981-1984 by Malaria! |
 |
Malaria: Fever Wars Starring: Artist Not Provided |
 |
First Comes Love, Then Comes Malaria: How a Peace Corps Poster Boy Won My Heart and a Third World Adventure Changed My Life by Eve Brown-Waite (Author) In this laugh-out-loud funny memoir, a pampered city girl falls head over little black heels in love with a Peace Corps poster boy and follows him —literally–to the ends of the earth. Eve Brown always thought she would join the Peace Corps someday, although she secretly worried about life without sushi, frothy coffee drinks and air conditioning. But with college diploma in hand, it was time to put up or shut up. So with some ambivalence she arrives at the Peace Corps office–sporting her best safari chic attire –to casually look into the steps one might take if one were to become a global humanitarian, a la Angelina Jolie. But when Eve meets John, her dashing young Peace Corps recruiter, all her ambivalence flies out the window. She absolutely must join the Peace Corps -... |
 |
Compiled 1981-84 Malaria! (Primary Contributor) |
 |
Parasites! - The Malaria Parasite by Sheila Wyborny (Author) Malaria is a serious disease caused by a tiny mosquito-borne parasite called Plasmodium. It once affected entire empires, but thanks to the work of health organizations, malaria is now mostly confined to warm, moist climates. Scientists are still at work today, however, developing methods of curing the disease and destroying its carriers. |
 |
Molecular Approaches to Malaria by Irwin W. Sherman (Editor) "Molecular Approaches to Malaria" provides an overview of the rapid and significant developments that have occurred in malaria research, including the 2002 genome sequencing of Plasmodium falciparum and its mosquito vector, Anopheles gambiae. This work: provides a concise source of up-to-date research findings; appeals to a diverse audience, including malaria researchers, teachers, investigators, and public health professionals; offers contributions by recognized malaria researchers with practical experience; and, presents comprehensive coverage of topics including a clearly written introduction to Plasmodium molecular biology. |
| © 2009 BrightSurf.com |